MAP2K7 and acute lymphoblastic leukemia: To confirm that 5Z7O cytotoxicity is mediated through MAP2K7 inhibition, we assessed the MAP2K7 pathway through immunoblots using a panel of T-ALL cell lines and LCL cells as controls.